Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:18 PM
Ignite Modification Date:
2025-12-24 @ 1:18 PM
NCT ID:
NCT06864195
Eligibility Criteria:
Inclusion Criteria:
* Males and females
* Adult participants ≥ 18 years old
* Participants with either:
1. Histologically or radiologically-confirmed\* hepatocellular carcinoma or cholangiocarcinoma (participants with liver cancer)
2. Liver cirrhosis, confirmed on imaging or histology from biopsy (participants with benign liver disorders)
3. Primary sclerosing cholangitis, confirmed on MRCP/ERCP or histology from biopsy (participants with benign liver disorders)
4. Non-specific gastrointestinal symptoms, but a radiologically-normal liver (healthy controls)
Exclusion Criteria:
* Active infection, or receiving immunosuppressive medications, within the preceding eight weeks
* History of another cancer within the previous five years
* Previous liver resection
* Already received chemotherapy, radiotherapy or surgery for their liver cancer
* Comorbidities preventing breath collection
* Pregnant women (checked verbally with participant).
* Unable to provide informed written consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06864195
Study Brief:
Protocol Section:
NCT06864195